Two inhibitors of yeast plasma membrane ATPase 1 ( Sc Pma1p): toward the development of novel antifungal therapies
JOURNAL OF CHEMINFORMATICS(2018)
摘要
Given that many antifungal medications are susceptible to evolved resistance, there is a need for novel drugs with unique mechanisms of action. Inhibiting the essential proton pump Pma1p, a P-type ATPase, is a potentially effective therapeutic approach that is orthogonal to existing treatments. We identify NSC11668 and hitachimycin as structurally distinct antifungals that inhibit yeast Sc Pma1p. These compounds provide new opportunities for drug discovery aimed at this important target.
更多查看译文
关键词
Saccharomyces cerevisiae
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要